îíëàéí-÷àò
WhatsApp
ðàäû ïîìî÷ü!

Êàòàëîã ëåêàðñòâ

Êîìáèíèðîâàííûå ïðåïàðàòû èíãèáèòîðîâ àíãèîòåíçèíà ii / ÑÌÎÒÐÈÒÅ ÄÅÒÀËÜÍÅÅ ÏÎ ÐÓÁÐÈÊÀÌ
  • Ãëàâíàÿ
  • ->
  • Êîìáèíèðîâàííûå ïðåïàðàòû èíãèáèòîðîâ àíãèîòåíçèíà ii
ÊÈÍÇÀËÊÎÌÁ (Òåëüìèçàðòàí) / KINZALKOMB (telmisartan)
òàáë. 80 ìã / 25 ìã / 98 øò.
Bayer Vital

íåò â íàëè÷èè
â çàêàç!
ÊÈÍÇÀËÊÎÌÁ (Òåëüìèçàðòàí) / KINZALKOMB (telmisartan)
òàáë. 80 ìã / 12,5 ìã / 98 øò.
Bayer Vital

íåò â íàëè÷èè
â çàêàç!
ÊÎ-ÝÊÑÔÎÐÆ (ãèäðîõëîðîòèàçèä+ âàëñàðòàí+àìëîäèïèí) / EXFORGE HCT (amlodipine + valsartan + hydrochlorothiazide)
òàáë. ï/î, 10 ìã + 160 ìã + 12,5 ìã / 28 øò.
Novartis

íåò â íàëè÷èè
â çàêàç!
ÊÎ-ÝÊÑÔÎÐÆ (ãèäðîõëîðîòèàçèä+ âàëñàðòàí+àìëîäèïèí) / EXFORGE HCT (amlodipine + valsartan + hydrochlorothiazide)
òàáë. ï/î, 5 ìã + 160 ìã + 12,5 ìã / 28 øò.
Novartis

íåò â íàëè÷èè
â çàêàç!
ÊÎÀÏÐÎÂÅËÜ (Èðáåçàðòàí) / COAPROVEL (hydrochlorothiazide + irbesartan)
òàáë. ï/î 300 ìã + 25 ìã / 98 øò.
Sanofi-Aventis

íåò â íàëè÷èè
â çàêàç!
ÊÎÀÏÐÎÂÅËÜ (Èðáåçàðòàí) / COAPROVEL (hydrochlorothiazide + irbesartan)
òàáë. ï/î 300 ìã + 12,5 ìã / 98 øò.
Sanofi-Aventis

íåò â íàëè÷èè
â çàêàç!
ÊÎÀÏÐÎÂÅËÜ (Èðáåçàðòàí) / COAPROVEL (hydrochlorothiazide + irbesartan)
òàáë. ï/î 300 ìã + 12,5 ìã / 28 øò.
Sanofi-Aventis

íåò â íàëè÷èè
â çàêàç!
ËÎÇÀÏ Ïëþñ (ëîçàðòàí êàëèÿ, ãèäðîõëîðîòèàçèä) / LOZAP Plus (potassium losartan, hydrochlorothiazide)
òàáë. ï/î 50 ìã + 12,5 ìã / 30 øò.
Zentiva

íåò â íàëè÷èè
â çàêàç!
ËÎÇÀÏ Ïëþñ (ëîçàðòàí êàëèÿ, ãèäðîõëîðîòèàçèä) / LOZAP Plus (potassium losartan, hydrochlorothiazide)
òàáë. ï/î 50 ìã + 12,5 ìã / 90 øò.
Zentiva

íåò â íàëè÷èè
â çàêàç!
ËÎÇÀÐÒÀÍ-Í ÐÈÕÒÅÐ (ãèäðîõëîðîòèàçèä+ëîçàðòàí) / LOSARTAN-N RICHTER (hydrochlorothiazide+losartan)
òàáë. ïîêð. ïëåíî÷íîé îáîëî÷êîé, 12,5 ìã+50 ìã / 30 øò.
Gedeon Richter

íåò â íàëè÷èè
â çàêàç!



Ïîìîùü
Êàê íàéòè ìåäèêàìåíòû
Íàéòè èíòåðåñóþùåå ëåêàðñòâî è åãî àíàëîãè Âû ñìîæåòå äàæå, åñëè íå óâåðåíû â ïðàâèëüíîñòè íàïèñàíèÿ åãî íàçâàíèÿ.
Ïîäðîáíåå
Îáìåí è âîçâðàò ìåäèêàìåíòîâ
Ñîãëàñíî Ïðàâèëàì ðåàëèçàöèè ëåêàðñòâåííûõ ñðåäñòâ ëåêàðñòâåííûå ñðåäñòâà, ïðåäìåòû ñàíèòàðíîé ãèãèåíû, ëåêàðñòâåííûå êîñìåòè÷åñêèå ñðåäñòâà äîëæíîãî êà÷åñòâà íå ïîäëåæàò îáìåíó èëè âîçâðàòó.
Ïîäðîáíåå
Ïîèñê è ðåçåðâèðîâàíèå ëåêàðñòâ, ïðåïàðàòîâ, ìåäèêàìåíòîâ
Èíôîðìàöèÿ î ïîèñêå íà ñåðâèñå Ëèêèòîðèÿ
Ïîäðîáíåå
15 Íîÿáðÿ 2026
Íåäîñòàòî÷íîå ïîòðåáëåíèå æèäêîñòè ñïîñîáíî íåãàòèâíî âëèÿòü íà ðàáîòó âñåãî îðãàíèçìà. Âàæíî âîâðåìÿ çàìå÷àòü ïðèçíàêè îáåçâîæèâàíèÿ è ïðèíèìàòü ìåðû äëÿ âîññòàíîâëåíèÿ âîäíîãî áàëàíñà.
08 Íîÿáðÿ 2026
Ïëàíèðóåìûé ìîäóëü ïðîâåðêè âçàèìîäåéñòâèé ëåêàðñòâ ïîìîæåò ïîëüçîâàòåëÿì ïîëó÷àòü ïðåäóïðåæäåíèÿ î ïîòåíöèàëüíî íåæåëàòåëüíûõ êîìáèíàöèÿõ ïðåïàðàòîâ.